News & Media

After an encounter with a not-for-profit organisation raising scientific literacy in NZ, Izon Science would like to share their story in the hope of garnering further support for the House of Science.

Sharing the story of France-based researcher Dr Gwennan André-Grégoire, who is working on unravelling the EV-related pathophysiology of glioblastoma multiforme.

Four reasons why storage conditions matter to the world of extracellular vesicle research.

An optimised, clinically relevant method for proteomic analysis of plasma EVs, featuring qEV isolation, is now documented in Cell Reports Methods.

Izon Science has recently executed a Product Development Agreement with BCAL Diagnostics.

On World Hepatitis Day 2021, we explore how researchers are pursuing extracellular vesicles as a way to improve outcomes for people with hepatitis.

A summary of work by Caputo et al (2021) who conducted a side-by-side comparison of ten analytical techniques for the characterisation of nanoplastics and microplastics.

BCAL Diagnostics is now listed on Australia’s sharemarket, the ASX. Izon Science and BCAL are co-developing the EV purification process for BCAL’s novel breast cancer test.

Key points from the fourth and final ISEV 2021 plenary talk by Jean Gruenberg, who discussed his group’s recent studies of tetraspanin sorting, endosomal membrane tension and ILV formation.

Highlights from the third ISEV 2021 plenary talk by Simon Carding, University of East Anglia, who discussed bacteria-derived EVs, their dynamics in the gut and their potential as drug delivery vehicles.

A wrap-up of the second ISEV 2021 plenary talk by Chantal Boulanger, INSERM. Here, the focus was on EVs in relation to arterial contraction and myocardial infarction.

A summary of the first ISEV 2021 plenary session by Andrew Hill, La Trobe University. This presentation explored EVs and their role in neurogenerative diseases, with a particular focus on prion diseases.

To help you select a suitable method for your research, we identified three key questions that get to the core of what’s important for characterising nanoparticles.

How is TRPS used to derive EV characteristics? How has a post-processing protocol created new possibilities for zeta potential analysis? Find out in this wrap-up of the ISEV2021 presentation by Dr. Priscila Dauros-Singorenko.

Attending ISEV 2021? Here are a few pointers on what to expect, and how to get the most out of this virtual event.

In brief: a summary of work by Vogel et al. (2021), who compared six methods for nanoparticle analysis, and assessed their capabilities using synthetic and biological nanovesicles of varying complexity.

To strengthen the analysis of nanoparticle size, concentration, and charge, Izon Science has released the Exoid – a new-generation Tunable Resistive Pulse Sensing (TRPS) technology.

Dr Gwennan André-Grégoire is a researcher affiliated with the Integrated Center for Cancerology (ICO), working in the Cancerology and Immunology Research Center Nantes-Angers (CRCINA), a public laboratory. Her current position in the Signaling in Oncogenesis, Angiogenesis and Permeability (SOAP) group—led by Dr Julie Gavard—follows a PhD and postdoctoral position in Paris, and previous postdoctoral position in the SOAP group.

A robust antibody titer is essential in preventing lung lesions associated with Actinobacillus pleuropneumoniae (App) – as discussed in this interview with Dr. Fabio Antenucci, University of Copenhagen.

If you are yet to join the high-definition revolution, we recommend you read these three studies that harness the accuracy of TRPS measurements.

Exploring the changing landscape of cannabis legislation in the US: implications for the biopharma sector.

A 2017 study published in Reproductive Biology report a new method which uses qEV columns to isolate exosomes from bovine milk.

The qEV100, a size exclusion chromatography column capable of running 100 mL samples, has been released to meet the growing need for scalable, EV isolation solutions.

In 2015, results from a large-scale trial demonstrated the reproducibility of SEC isolation and TRPS measurement using qEV columns and the qNano.

Continuing advances in the EV field and the discovery of new types of nanosized particles (e.g. exomeres), has led to researchers wanting more specific and precise EV isolation methods.

A wrap-up of a conversation with Dr. Maja Mustapic, Staff Scientist at the Kapogiannis Laboratory, Laboratory of Neurosciences, National Institute on Aging (NIA).

A reflection of the 7th annual meeting of the American Society for Exosomes and Microvesicles, held at Pacific Beach, California. Key themes included cancer metastasis and EV isolation methods.

In this interview, Dr de Gracia Lux from UT Southwestern Medical Center discusses the pursuit of phase change perfluorocarbon nanodroplets for diagnostic and therapeutic applications.

Izon’s qEV columns harness size exclusion chromatography (SEC) to provide a rapid and effective method for the isolation of exosomes and other extracellular vesicles.

Two researchers from the Paris Cardiovascular Research Centre, Dr. Pierre-Michaël Coly and Stephane Mazlan, discuss how they are decoding the role of EVs in cardiovascular health.